Biotech startup funding holds steady amid AI surge
Even as startup investment set new records—driven by generative AI—biotech funding has stayed steady, sticking between $36 and $40 billion globally for several years. AI-focused biotechs raised a notable $6 billion so far this year, with London’s Isomorphic Labs landing the largest biotech round at $2.1 billion. Most biotech funding still goes to early-stage startups, and several, like Kailera Therapeutics, have gone public early.
- Global biotech funding stuck near $36–40 billion yearly
- AI-focused biotechs raised over $6 billion this year
- Isomorphic Labs led with $2.1 billion Series B
- Early-stage biotech rounds make up most of the total
- Some biotechs now go public soon after early funding
Sources covering this
More in Startups
Nua raises $50 million for women's wellness products
Nua, a Mumbai-based startup making wellness products for women, just raised $50 million in Series C funding. Peak XV Partners and Filter Capital led the round. Nua says they've grown their yearly revenue fivefold in two years, hitting about ₹500 crore, and stayed profitable. The new money will go to expanding their product range, boosting distribution, and investing in R&D. Several early investors took partial exits.
Pixxel raises $100M to boost satellite imaging
Pixxel just raised $100 million in Series C funding, led by Temasek and Seraphim, bringing its total backing to $195 million. That’s now the biggest single investment round an Indian space startup has pulled in, according to Pixxel. The company says it’ll use the funds to expand its imaging satellites, improve its Aurora earth intelligence software, and ramp up manufacturing at its Bangalore plant.
Félix raises $200M for WhatsApp remittance tool
Félix, which lets Latino immigrants send money home via WhatsApp, just raised $200 million in Series C funding. Andreessen Horowitz put in $87 million of equity; General Catalyst gave $113 million in growth debt. The Miami startup says it’s handled over $8 billion in payments so far, serving U.S. users with families in 11 Latin American countries. Félix plans to expand into new markets with the cash.
Venture-backed startup IPOs surge past $110 billion in 2026
So far in 2026, private startups have raised $110.8 billion from IPOs—almost nine times last year’s haul for the same stretch, thanks mostly to SpaceX’s $86 billion debut in June. Crunchbase flags more to watch before year-end, including Anthropic, which could go public as soon as September or October and reportedly may raise up to $100 billion if it does.